Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Supplemental Equity and Accumulated Other Comprehensive Income (Loss) - Changes in Accumulated Other Comprehensive Income (Loss), Net of Tax (Details)

v3.22.0.1
Note 8 - Supplemental Equity and Accumulated Other Comprehensive Income (Loss) - Changes in Accumulated Other Comprehensive Income (Loss), Net of Tax (Details) - USD ($)
$ in Thousands
 6 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Balance $ 1,562,971  
Balance 1,702,989  
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]    
Balance (6,193) $ (13,253)
Other comprehensive income (loss) before reclassifications, net of taxes, attributable to Bio-Techne 1,682 (47)
Reclassification from loss on derivatives to interest expense, net of taxes, attributable to Bio-Techne(1) 2,884 [1] 4,249 [2]
Balance [3] (1,626) (9,051)
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]    
Balance (51,098) (83,946)
Other comprehensive income (loss) before reclassifications, net of taxes, attributable to Bio-Techne (6,750) 28,759
Reclassification from loss on derivatives to interest expense, net of taxes, attributable to Bio-Techne(1) 0 [1] 0 [2]
Balance [3] (57,848) (55,187)
AOCI Attributable to Parent [Member]    
Balance (57,291) (97,199)
Other comprehensive income (loss) before reclassifications, net of taxes, attributable to Bio-Techne (5,068) 28,712
Reclassification from loss on derivatives to interest expense, net of taxes, attributable to Bio-Techne(1) 2,884 [1] 4,249 [2]
Balance [3] $ (59,474) $ (64,238)
[1] Gains (losses) on the interest swap are reclassified into interest expense as payments on the derivative agreement are made. The Company reclassified $3,777 to interest expense and a related tax benefit of $892 during the six months ended December 31, 2021.
[2] Gains (losses) on the interest swap are reclassified into interest expense as payments on the derivative agreement are made. The Company reclassified $5,026 to interest expense and $512 to non-operating income relating to variable interest payments that were probable not to occur in the six months ended December 31, 2020. The Company also recorded a related tax benefit of $1,289 during the six months ended December 31, 2020.
[3] The Company had net deferred tax benefits of $502 and $2,886 included in the accumulated other comprehensive income loss as of December 31, 2021 and 2020, respectively.